Clinical and laboratory-based methods in the diagnosis of natural rubber latex allergy

Schlagwörter: 

  • Dieses Thema ist leer.
Ansicht von 1 Beitrag (von insgesamt 1)
  • Autor
    Beiträge
  • #5780
    Swissallergy
    Moderator


    The accurate diagnosis of hypersensitivity to natural rubber latex is the initial step in the effective management of individuals with latex allergy and in ensuring the quality of epidemiologic studies. The diagnostic algorithm used in the evaluation of an individual with suspected latex allergy begins with a comprehensive clinical history during which risk factors (atopy, food allergies, hand dermatitis) and temporal relationships between symptoms and natural rubber product exposure are identified. If type IV hypersensitivity is suspected because of the delayed nature (hours to days) and confinement of symptoms to the skin-latex product contact areas, patch testing can be conducted to confirm the presence of activated T cells with specificity for rubber chemicals. If type I hypersensitivity is suspected because of ocular, upper and lower airway, and/or systemic symptoms that have rapid onset (minutes) after a definable latex exposure, a confirmatory skin or blood test for IgE antibody may be conducted to verify a state of sensitization within the individual.

    The definitive diagnosis would then be made only after consideration of the individual’s clinical history and confirmatory in vivo and/or in vitro laboratory test results. If discordance remains between highly convincing latex-associated symptoms as identified in the history and repetitively negative confirmatory IgE antibody test results, then one of several types of in vivo provocation tests may be performed for adjudication. This overview examines the current state of the art in both in vivo and in vitro diagnostic methods for latex-specific IgE antibody detection in skin and blood. The performance, advantages, and limitations of each diagnostic method are compared. (J Allergy Clin Immunol 2002;110:S47-56.)
    Full article: https://pubmed.ncbi.nlm.nih.gov/12170243/

Ansicht von 1 Beitrag (von insgesamt 1)
  • Du musst angemeldet sein, um auf dieses Thema antworten zu können.
Anmeldung zum Newsletter

Abonnieren Sie unseren kostenlosen monatlichen Newsletter, um Neuigkeiten und Tipps zu Gesundheitsthemen zu erhalten, die für Sie wichtig sind.